Amalia Raluca Ceausu

Dr. Amalia Raluca Ceausu

Victor Babeș University of Medicine and Pharmacy Timișoara, Timişoara, Timiş, Romania
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IVIoana Vornic
Ioana Vornic
VBVictor Bogdan Buciu
Victor Bogdan Buciu
Cristian FurauCristian Furau
Cristian Furau
PGPusa Nela Gaje
Pusa Nela Gaje
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
Flavia BadercaFlavia Baderca
Flavia Baderca
Oxidative stress (OS) plays a crucial role in placental pathogenesis and pregnancy-related complications. This review explores OS’s impact on placental development and function, focusing on novel biomarkers for the early detection of at-risk pregnancies and emerging therapeutic strategies. We analyzed recent research on OS in placental pathophysiology, examining its sources, mechanisms, and effects. While trophoblast invasion under low-oxygen conditions and hypoxia-induced OS regulate physiological placental development, excessive OS can lead to complications like miscarriage, preeclampsia, and intrauterine growth restriction. Promising OS biomarkers, including malondialdehyde, 8-isoprostane, and the sFlt-1/PlGF ratio, show potential for the early detection of pregnancy complications. Therapeutic strategies targeting OS, such as mitochondria-targeted antioxidants, Nrf2 activators, and gasotransmitter therapies, demonstrate encouraging preclinical results. However, clinical translation remains challenging. Future research should focus on validating these biomarkers in large-scale studies and developing personalized therapies to modulate placental OS. Emerging approaches like extracellular vesicle-based therapies and nanomedicine warrant further investigation for both diagnostic and therapeutic applications in pregnancy-related complications. Integrating OS biomarkers with other molecular and cellular markers offers improved potential for the early identification of at-risk pregnancies.

24 July 2013 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
IDIvanka Dimova
Ivanka Dimova
RHRuslan Hlushchuk
Ruslan Hlushchuk
AMAndrew Ndegwa Makanya
Andrew Ndegwa Makanya
BSBeata Styp-Rekowska
Beata Styp-Rekowska
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
Valentin DjonovValentin Djonov
Valentin Djonov

1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ODO M Duicu
O M Duicu
RLR Lighezan
R Lighezan
ASAdrian Sturza
Adrian Sturza
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
AVAdrian Vaduva
Adrian Vaduva
CMC Mornos
C Mornos
Mitochondria‐related oxidative stress is a pathomechanism causally linked to coronary heart disease (CHD) and diabetes mellitus (DM). Recently, mitochondrial monoamine oxidases (MAOs) have emerged as novel sources of oxidative stress in the cardiovascular system and experimental diabetes. The present study was purported to assess the mitochondrial impairment and the contribution of MAOs‐related oxidative stress to the cardiovascular dysfunction in coronary patients with/without DM. Right atrial appendages were obtained from 75 patients randomized into 3 groups: (1) Control (CTRL), valvular patients without CHD; (2) CHD, patients with confirmed CHD; and (3) CHD‐DM, patients with CHD and DM. Mitochondrial respiration was measured by high‐resolution respirometry and MAOs expression was evaluated by RT‐PCR and immunohistochemistry. Hydrogen peroxide (H2O2) emission was assessed by confocal microscopy and spectrophotometrically. The impairment of mitochondrial respiration was substrate‐independent in CHD‐DM group. MAOs expression was comparable among the groups, with the predominance of MAO‐B isoform but no significant differences regarding oxidative stress were detected by either method. Incubation of atrial samples with MAOs inhibitors significantly reduced the H2O2 in all groups. In conclusion, abnormal mitochondrial respiration occurs in CHD and is more severe in DM and MAOs contribute to oxidative stress in human diseased hearts with/without DM.

11 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
IVIoana Vornic
Ioana Vornic
VBVictor Bogdan Buciu
Victor Bogdan Buciu
Cristian FurauCristian Furau
Cristian Furau
PGPusa Nela Gaje
Pusa Nela Gaje
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
FZFlavia Zara
Flavia Zara
Oxidative stress (OS) plays a crucial role in placental pathogenesis and pregnancy-related complications. This review explores OS's impact on placental development and function, focusing on novel biomarkers for early detection of at-risk pregnancies and emerging therapeutic strategies. We analyzed recent research on OS in placental pathophysiology, examining its sources, mechanisms, and effects. While trophoblast invasion under low-oxygen conditions and hypoxia-induced OS regulate physiological placental development, excessive OS can lead to complications like miscarriage, preeclampsia, and intrauterine growth restriction. Promising OS biomarkers, including malondialdehyde, 8-isoprostane, and the sFlt-1/PlGF ratio, show potential for early detection of pregnancy complications. Therapeutic strategies targeting OS, such as mitochondria-targeted antioxidants, Nrf2 activators, and gasotransmitter therapies, demonstrate encouraging preclinical results. However, clinical translation remains challenging. Future research should focus on validating these biomarkers in large-scale studies and developing personalized therapies to modulate placental OS. Emerging approaches like extracellular vesicle-based therapies and nanomedicine warrant further investigation for both diagnostic and therapeutic applications in pregnancy-related complications. Integrating OS biomarkers with other molecular and cellular markers offers improved potential for early identification of at-risk pregnancies.

1 October 2016 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
RLRodica Lighezan
Rodica Lighezan
ASAdrian Sturza
Adrian Sturza
ODOana M. Duicu
Oana M. Duicu
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
AVAdrian Vaduva
Adrian Vaduva
CMCristian Mornos
Cristian Mornos
Monoamine oxidases (MAOs) are mitochondrial enzymes with 2 isoforms that have emerged as important contributors to cardiovascular oxidative stress via the constant generation of hydrogen peroxide. The present study was purported to assess whether MAO-derived H2O2 contributes to the endothelial dysfunction in mammary arteries harvested from coronary heart disease patients with and without diabetes mellitus subjected to coronary artery bypass grafting. To this aim, the effects of MAO inhibition on vascular contractility to phenylephrine and endothelial-dependent relaxation (EDR) in response to acetylcholine were studied in vascular segments. Clorgyline (irreversible MAO-A inhibitor), selegiline (irreversible MAO-B inhibitor), and moclobemide (reversible MAO-A inhibitor) were applied in the organ bath (10 μmol/L). MAO expression was assessed by immunohistochemistry. We found a constant impairment of EDR that has been significantly attenuated in the presence of the MAO-A and MAO-B inhibitors in both groups of coronary heart disease patients. MAO-B was the dominant isoform in all human diseased vessels. In conclusion, in vitro inhibition of MAO significantly improved EDR in human mammary arteries, regardless of the presence of diabetes. These data suggest that MAO inhibitors might be useful in restoring endothelial response in clinical conditions associated with increased oxidative stress, such as coronary artery disease and diabetes.

5 September 2012 in Oncology Letters
Verified
Journal Article
Open access
PDF file
ABAmalia Birau
Amalia Birau
Amalia Raluca CeausuAmalia Raluca Ceausu
Amalia Raluca Ceausu
Anca-Maria CimpeanAnca-Maria Cimpean
Anca-Maria Cimpean
PGPusa Gaje
Pusa Gaje
MRMarius Raica
Marius Raica
TOTeodora Olariu
Teodora Olariu
Despite advances in treatment, the prognosis for lung cancer patients remains poor. Angiogenesis appears to be a promising target for lung cancer therapy; however, the clinical significance of vascular changes are not completely understood. The aim of this study was to evaluate the types and morphology of blood vessels in various lung carcinomas. Using double immunostaining, we investigated 39 biopsies from patients admitted with various histological types of lung carcinoma. Tumor blood vessels were quantified separately for CD34/smooth muscle actin and described as either immature, intermediate or mature. Double immunostaining evaluation of the type of blood vessels in lung carcinomas revealed a marked heterogeneity. The immature and intermediate type of vessels were more common in adenocarcinomas (ADCs) and squamous cell carcinomas (SCCs) of the lung. Small cell lung carcinomas revealed a significant correlation between pathological and immature types of blood vessels. Therefore, quantifying the types of tumor vessels in lung carcinomas may be an important element to improve the results of anti-vascular therapy.